On Hold
AbbVie M16-904
AbbVie M16-904
To evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of Leuprolide Acetate 45 mg 6-month depot formulation in children with Central precocious puberty
Pediatric Diabetes
Enrolling
CIP321
CIP321
The purpose of the 321 trial is to evaluate the safety of the Advanced Hybrid Closed Loop system (AHCL) in pediatric type 1 diabetes subjects age 7 – 13 in a home setting. The main objective in conducting this research is to collect data from patients who use the AHCL system at home, at work, […]
On Hold
Protect – Type 1 Diabetes Study
Protect – Type 1 Diabetes Study
The Protect study will determine whether teplizumab slows the loss of β cells and preserves β cell function in children and adolescent 8-17 years old who have been diagnosed with T1D in the previous 6 weeks.
On Hold
Pronto-Peds Insulin Study
Pronto-Peds Insulin Study
The reason for this study is to compare a ultra-rapid lispro to insulin lispro (Humalog) in children and adolescents with type 1 diabetes (T1D).
Closed
Boehringer 1218
Boehringer 1218
This study will assess how well empagliflozin and linagliptin work in children and adolescents(DINAMO).
Enrolling
Closed Loop pump system
Closed Loop pump system
Seeking Type 1 pediatric subjects who are interested in using a new Closed Loop pump system (Med 304). Open now to patients using a pump and sensor
Closed
Libre Flash
Libre Flash
Seeking pediatric Type 1 subjects to assess accuracy and reliability of a new-to-market flash glucose monitoring system (Libre Flash).
Can’t find a study that works for you?
Subscribe for Information on Other Studies
Fill out the form below an we will let you know when a study becomes available that you may be interested in:
